Summation: β-lactam resistance surveillance in the Asia–Western Pacific Region
- 31 December 1999
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 35 (4) , 333-338
- https://doi.org/10.1016/s0732-8893(99)00110-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- In vitro evaluation of broad-spectrum β-lactams in the Philippines medical centers: role of fourth-generation cephalosporinsDiagnostic Microbiology and Infectious Disease, 1999
- In vitro evaluation of cefepime and other broad-spectrum β-lactams against bacteria from Indonesian medical centersDiagnostic Microbiology and Infectious Disease, 1999
- In vitro evaluation of cefepime and other broad-spectrum β-lactams for isolates in Malaysia and Singapore medical centersDiagnostic Microbiology and Infectious Disease, 1999
- In vitro evaluation of broad-spectrum β-lactams tested in medical centers in Korea: role of fourth-generation cephalosporinsDiagnostic Microbiology and Infectious Disease, 1999
- Multicenter Evaluation of the In Vitro Activity of Six Broad-Spectrum β-Lactam Antimicrobial Agents in Puerto RicoDiagnostic Microbiology and Infectious Disease, 1998
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- Inducible β-lactamase-mediated resistance to third-generation cephalosporinsClinical Microbiology & Infection, 1997
- Susceptibility of bacterial isolates to β-lactam antibiotics from U.S. clinical trials over a 5-year periodThe American Journal of Medicine, 1996
- CefepimeDrugs, 1994
- Evaluation of the E test, a novel method of quantifying antimicrobial activityJournal of Antimicrobial Chemotherapy, 1991